B. Braun said this week it inked a collaborative deal with Omnicell to help decrease the time and clinical support necessary to manage IV infusions and IV compounding.
Through the deal, Omnicell will be able to use B. Braun’s DoseTrac infusion management software through a hyperlink in Omnicell’s performance center, the companies said.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.